Insmed Inc header image

Insmed Inc

INSM

Equity

ISIN US4576693075 / Valor 12614415

NASDAQ (2024-09-18)
USD 72.87-0.53%

Insmed Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Insmed Inc is a pharmaceutical company founded in Virginia that focuses on developing medicines for the treatment of various diseases, including lung diseases and diabetes. The company has expanded its rare disease pipeline through strategic financings, worldwide license agreements, and acquisitions. Insmed's global headquarters in New Jersey supports its continued growth, and the company has recently acquired late-stage candidates to further enhance its product portfolio.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

174%1Y
172%3Y
276%5Y

Performance

88.3%1Y
66.7%3Y
67.4%5Y

Volatility

Market cap

12590 M

Market cap (USD)

Daily traded volume (Shares)

607,601

Daily traded volume (Shares)

1 day high/low

74.53 / 72.655

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

MedNation AG
MedNation AG MedNation AG Valor: 331107
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.46
Viking Therapeutics Inc
Viking Therapeutics Inc Viking Therapeutics Inc Valor: 24839858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.40%USD 64.45
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc Protagonist Therapeutics Inc Valor: 33278818
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.31%USD 44.77
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.33%USD 24.56
Shattuck Labs Inc
Shattuck Labs Inc Shattuck Labs Inc Valor: 57260669
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.40%USD 3.66
Quanterix Corporation
Quanterix Corporation Quanterix Corporation Valor: 39127916
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.12%USD 14.14
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. Nano-X Imaging Ltd. Valor: 56410599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 6.26
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 34.34
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.02%USD 4.60
KK GNI Group
KK GNI Group KK GNI Group Valor: 3303570
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.38%JPY 2,493.00